Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

National Reye's Syndrome Foundation

Executive Summary

Requests that FDA-mandated labeling for products containing aspirin be extended to all salicylate-containing products. "Too many cases of Reye's Syndrome have suspiciously been linked to one product in particular, [Procter & Gamble's] Pepto-Bismol, to account for it being coincidental," Chicago Chapter President Carolyn Jender maintained in a recent letter to FDA. The foundation believes that 20%-25% of Reye's Syndrome reported cases are the result of salicylate-containing products.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS015794

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel